A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
Conditions
- BRAF V600E Mutation Positive
- Metastatic Colorectal Cancer
Interventions
- OTHER: Non interventional
Sponsor
Pierre Fabre Medicament
Collaborators